https://www.barrons.com/articles/astrazeneca-stock-dato-breast-cancer-drug-trial-180496d5
0
0
9/22/23 at 3:34pm
Organization
Barron's
Author
Emily Dattilo
34 words
0
Comments
The drugmaker says the trial demonstrated a statistically significant and clinically meaningful improvement for the primary endpoint of progression-free survival.
You are the first to view
Create an account
or login to join the discussion